Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.
Renna S, Orlando E, Macaluso FS, Maida M, Affronti M, Giunta M, Sapienza C, Rizzuto G, Orlando R, Dimarco M, Cottone M, Orlando A.
Renna S, et al. Among authors: orlando e, orlando a, orlando r.
Aliment Pharmacol Ther. 2016 Aug;44(3):310-1. doi: 10.1111/apt.13692.
Aliment Pharmacol Ther. 2016.
PMID: 27375103
Free article.
No abstract available.